To show the full potential of CONNECTOR in a complex use case, we analyzed a large dataset of tumor growth curves of PDXs from mice treated with cetuximab, an anti-EGFR antibody that is approved for clinical use in patients with RAS/RAF wild-type mCRC. This evidence concerns the gene EGFR and neoplasm.